Long-term protection from myocardial ischemic events in a randomized trial of brief integrin β
3blockade with percutaneous coronary intervention. JAMA - Journal of the American Medical Association. 1997 Academic Article GET IT
Times cited: 428
Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors.
Journal of the American College of Cardiology.
Times cited: 151
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.
Times cited: 405